The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER‐positive breast cancers
Publisher: John Wiley & Sons Inc
E-ISSN: 1098-2744|54|10|1172-1180
ISSN: 0899-1987
Source: Molecular Carcinogenesis, Vol.54, Iss.10, 2015-10, pp. : 1172-1180
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract